ANALYSIS OF THE EFFECTIVENESS OF BRONCHIAL ASTHMA THERAPY IN CHILDREN USING THE REGIONAL REGISTER

Abstract

Purpose: to analyze the justification and adequacy of prescribing preferential drugs in accordance with the severity of bronchial asthma.Materials and methods: a retrospective analysis of the adequacy of provision of preferential medicines to 160 patients withatopic bronchial asthma for 2019 according to the Regional Register of Asthma. All children were combined into 4 groups of 40 people each: with mild intermittent, mild persistent, moderate and severe severity.Results: according to the register, the therapy of patients with mild intermittent and persistent bronchial asthma was in full, witha tendency to increase due to the use of combined drugs, antagonists of leukotriene receptors, genetic engineering drugs with moderate and severe bronchial asthma. Analysis of the data demonstrates that not all patients are prescribed basic therapy drugs in a timely manner in full and in accordance with federal clinical recomendations, which requires a review of the severity of bronchial asthma.Conclusions: the study showed that a quarterly adjustment of the volume of therapy and prescribed preferential drugs, depending on the severity of the disease, is justified and economically feasible.